Sign Out
No cases of overdose have been reported in clinical studies.
Doses up to 280 mg have been administered subcutaneously in clinical studies with no evidence of dose-limiting toxicity.
In the event of an overdose, the patient should be treated symptomatically and supportive measures instituted as required.
